Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of ezetimibe 10 mg tablets in healthy Thai volunteers
TCTR20161219002Phase 1Completed
- Sponsor
- International Bio Service
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax of ezetimibe, AUC0-tlast of ezetimibe and 4 more. Started Jun 2017; status: completed.
02
Drugs
ezetimibe
Beyond the preview
Go deeper on TCTR20161219002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20161219002.